Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-028756

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David A Pierce
Officer — SVP and President, Endoscopy
Period of report
Feb 27, 2016
Accepted (ET)
Mar 1, 2016 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 27, 2016M3,185$0.00A74,691D
Common StockFeb 27, 2016F1,501$17.21D73,190D
Common StockF1Feb 28, 2016M4,398$0.00A77,588D
Common StockF1Feb 28, 2016M3,492$0.00A81,080D
Common StockFeb 28, 2016F3,717$17.21D77,363D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF1,F2—Feb 27, 2016M3,185D—Feb 27, 2017Common Stock3,1853,185D
Deferred Stock UnitsF1,F3—Feb 28, 2016M3,492D—Feb 28, 2016Common Stock3,4920D
Deferred Stock UnitsF1,F4—Feb 28, 2016M4,398D—Feb 28, 2018Common Stock4,3988,796D

Explanation of responses